SynAct Pharma AB
559058-4826ActiveClinical-stage biotech resolving inflammation via novel oral therapies.
Oversikt
- 5–9
- Ansatte
- 5–10mill SEK
- Omsetning
- 2016
- Grunnlagt
Nøkkelbeslutningstakere
Ann Kristin Led
Chief Financial Officer
Jeppe Øvlesen
Chief Executive Officer
Roy Fleischmann
Advisory Board Member
Ravi Rao
Advisory Board Member
+18 flere kontakter i Funnelfeedr
Beskrivelse
SynAct Pharma is a clinical-stage biotechnology company dedicated to developing innovative medicines. Its core scientific approach centers on "Resolution Therapy," aiming to actively resolve ongoing inflammatory processes rather than merely inhibiting them. This strategy seeks to restore immune bala...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559058482601
Beslutningstakere
22 kontakter i FunnelfeedrAnn Kristin Led
Chief Financial Officer
Jeppe Øvlesen
Chief Executive Officer
Roy Fleischmann
Advisory Board Member
Ravi Rao
Advisory Board Member
Mauro Perretti
Advisory Board Member
Björn Westberg
Chief Financial Officer
Malin Wikstrand
Interim Chief Financial Officer
Jeppe Ragnar Andersen
Board Member
Thomas Boesen, PhD.
Chief Operating Officer
Sten Sørensen
Board Member
Thomas Boesen
Chief Operating Officer
Thomas Jonassen, MD.
Chief Scientific Officer
James Knight
Advisory Board Member
Vibeke Strand
Advisory Board Member
Thomas Jonassen
Chief Scientific Officer
Sten Scheibye
Board Member
Mads Bjerregaard
Chief Business Officer
Kirsten Harting
Chief Medical Officer
Sten Sörensen
Board Member
Anders Kronborg
Chairman of the Board
Torbjørn Bjerke
Chief Executive Officer
Mauro Teixeira
Advisory Board Member
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrSynartro AB
1–4 ansatteDeveloping sustained local injection treatments for osteoarthritis pain relief.
Pharmnovo Aktiebolag
1–4 ansatteDeveloping non-addictive delta opioid receptor agonists for neuropathic pain.
Sangair AB
3 ansatteDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Novakand Pharma AB
5–9 ansatteDeveloping novel small-molecule drugs for inflammation and cancer.
PILA PHARMA AB
1–4 ansatteClinical stage biotech developing an oral obesity and diabetes treatment.
Utforsk mer
Spørsmål om SynAct Pharma AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo